156 related articles for article (PubMed ID: 36757050)
1. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3β/β-Catenin Signaling.
Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
[TBL] [Abstract][Full Text] [Related]
2. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
Deng F; Zhou K; Cui W; Liu D; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
[TBL] [Abstract][Full Text] [Related]
4. MYH9 promotes cell metastasis
Yang B; Liu H; Bi Y; Cheng C; Li G; Kong P; Zhang L; Shi R; Zhang Y; Zhang R; Cheng X
Int J Med Sci; 2020; 17(13):2013-2023. PubMed ID: 32788880
[TBL] [Abstract][Full Text] [Related]
5. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
6. TRIM36 suppresses cell growth and promotes apoptosis in human esophageal squamous cell carcinoma cells by inhibiting Wnt/β-catenin signaling pathway.
Zhao B; Qiao G; Li J; Wang Y; Li X; Zhang H; Zhang L
Hum Cell; 2022 Sep; 35(5):1487-1498. PubMed ID: 35768649
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
[TBL] [Abstract][Full Text] [Related]
9. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.
Duan X; Chen Y; Zhang K; Chen W; Zhao J; Dai X; Cao W; Dong Z; Mo S; Lu J
Cell Signal; 2023 Sep; 109():110736. PubMed ID: 37263462
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma.
Meng J; Zhang C; Zhao T; Shi G; Zhao J; Lin Z
Thorac Cancer; 2021 Mar; 12(6):932-940. PubMed ID: 33538099
[TBL] [Abstract][Full Text] [Related]
11. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.
Ai R; Sun Y; Guo Z; Wei W; Zhou L; Liu F; Hendricks DT; Xu Y; Zhao X
Cancer Biol Ther; 2016 Sep; 17(9):943-54. PubMed ID: 27414086
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
14. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
[TBL] [Abstract][Full Text] [Related]
15. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of TNFAIP2 suppresses proliferation and metastasis in esophageal squamous cell carcinoma through activation of the Wnt/β-catenin signaling pathway.
Xie Y; Wang B
Oncol Rep; 2017 May; 37(5):2920-2928. PubMed ID: 28393234
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
Wang P; Li L; Li T
J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
[TBL] [Abstract][Full Text] [Related]
19. TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.
Gao A; Su Z; Shang Z; He C; Miao D; Li X; Zou S; Ding W; Zhou Y; Sun M; Zhou J
Cell Death Dis; 2022 Oct; 13(10):900. PubMed ID: 36289198
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.
Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H
Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]